• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Bethesda system for reporting thyroid cytopathology in Colombia: Correlation with histopathological diagnoses in oncology and non-oncology institutions.哥伦比亚甲状腺细胞病理学报告的贝塞斯达系统:与肿瘤学和非肿瘤学机构组织病理学诊断的相关性。
J Cytol. 2015 Jan-Mar;32(1):12-6. doi: 10.4103/0970-9371.155224.
2
[On-site fine-needle aspiration cytology of thyroid nodules. Quality assurance of the Bethesda System for Reporting Thyroid Cytopathology (2008)].[甲状腺结节的现场细针穿刺细胞学检查。甲状腺细胞病理学报告贝塞斯达系统(2008年)的质量保证]
Orv Hetil. 2015 Oct 11;156(41):1661-6. doi: 10.1556/650.2015.30268.
3
Study of Fine Needle Aspiration Cytology (FNAC) of Thyroid Gland According to the Bethesda System.根据贝塞斯达系统对甲状腺细针穿刺细胞学(FNAC)的研究。
Cureus. 2023 Apr 10;15(4):e37371. doi: 10.7759/cureus.37371. eCollection 2023 Apr.
4
Diagnostic accuracy of Bethesda system for reporting thyroid cytopathology: an institutional perspective.贝塞斯达系统报告甲状腺细胞病理学的诊断准确性:机构视角
Int Arch Med. 2014 Oct 31;7:46. doi: 10.1186/1755-7682-7-46. eCollection 2014.
5
Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.贝塞斯达分类法是细针穿刺报告的重要指南,尤其对诊断甲状腺乳头状癌的侵袭性变体具有高度预测性。
Cytopathology. 2017 Aug;28(4):259-267. doi: 10.1111/cyt.12384. Epub 2016 Sep 25.
6
The Bethesda System for Reporting Thyroid Cytopathology is applicable to frozen section diagnosis in children.《甲状腺细胞病理学报告的贝塞斯达系统》适用于儿童的冰冻切片诊断。
Pediatr Dev Pathol. 2015 Mar-Apr;18(2):139-45. doi: 10.2350/14-08-1542-OA.1. Epub 2015 Jan 27.
7
To Establish Bethesda System for Diagnosis of Thyroid Nodules on the Basis of Fnac with Histopathological Correlation.基于细针穿刺活检(FNAC)并与组织病理学相关联建立甲状腺结节的贝塞斯达诊断系统。
J Clin Diagn Res. 2015 Dec;9(12):EC17-21. doi: 10.7860/JCDR/2015/14823.6897. Epub 2015 Dec 1.
8
Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): Implications for the risk of malignancy (ROM) in the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC).非侵袭性滤泡性甲状腺肿瘤伴乳头状核特征(NIFTP):对甲状腺细胞病理学报告的 Bethesda 系统(TBSRTC)中恶性肿瘤风险(ROM)的影响。
Cancer Cytopathol. 2018 Jan;126(1):20-26. doi: 10.1002/cncy.21926. Epub 2017 Sep 20.
9
Cytological Evaluation of Thyroid Lesions by Nuclear Morphology and Nuclear Morphometry.通过核形态学和核形态计量学对甲状腺病变进行细胞学评估。
J Cytol. 2017 Oct-Dec;34(4):197-202. doi: 10.4103/JOC.JOC_87_16.
10
Evaluation of Fine-Needle Aspiration of Thyroid Nodules in a Series of 1,100 Patients: Correlation Between Cytology and Histopathology Original Article.1100例患者甲状腺结节细针穿刺抽吸的评估:细胞学与组织病理学的相关性 原创文章
Indian J Surg. 2015 Dec;77(Suppl 3):990-5. doi: 10.1007/s12262-014-1102-x. Epub 2014 May 24.

引用本文的文献

1
A study of machine learning models for rapid intraoperative diagnosis of thyroid nodules for clinical practice in China.一项关于机器学习模型在甲状腺结节术中快速诊断中应用的研究,旨在为中国的临床实践提供参考。
Cancer Med. 2024 Feb;13(3):e6854. doi: 10.1002/cam4.6854. Epub 2024 Jan 8.
2
Study of Fine Needle Aspiration Cytology (FNAC) of Thyroid Gland According to the Bethesda System.根据贝塞斯达系统对甲状腺细针穿刺细胞学(FNAC)的研究。
Cureus. 2023 Apr 10;15(4):e37371. doi: 10.7759/cureus.37371. eCollection 2023 Apr.
3
Is There a Role for Molecular Testing for Low-Risk Differentiated Thyroid Cancer? A Cost-Effectiveness Analysis.低风险分化型甲状腺癌的分子检测是否有作用?一项成本效益分析。
Cancers (Basel). 2023 Jan 27;15(3):786. doi: 10.3390/cancers15030786.
4
Reproducibility of Cytomorphological Diagnosis and Assessment of Risk of Malignancy of Thyroid Nodules Based on the Bethesda System for Reporting Thyroid Cytopathology: A Tertiary Cancer Center Perspective.基于甲状腺细胞病理学报告的贝塞斯达系统的甲状腺结节细胞形态学诊断的可重复性及恶性风险评估:三级癌症中心视角
J Microsc Ultrastruct. 2022 Dec 1;10(4):174-179. doi: 10.4103/jmau.jmau_88_21. eCollection 2022 Oct-Dec.
5
Molecular features of aggressive thyroid cancer.侵袭性甲状腺癌的分子特征
Front Oncol. 2022 Dec 20;12:1099280. doi: 10.3389/fonc.2022.1099280. eCollection 2022.
6
Usefulness of The Bethesda System of Reporting Thyroid Cytopathology in Surgical Planning.《贝塞斯达系统报告甲状腺细胞病理学在手术规划中的实用性》
Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):2623-2628. doi: 10.1007/s12070-020-02335-5. Epub 2021 Jan 7.
7
Cytomorphological Categorization of Thyroid Lesions according to The Bethesda System for Reporting Thyroid Cytology and Correlation with their Histological Outcome: An Indian Oncology Centre Experience.根据甲状腺细胞病理学报告的贝塞斯达系统对甲状腺病变进行细胞形态学分类及其与组织学结果的相关性:一家印度肿瘤中心的经验
J Cytol. 2022 Jan-Mar;39(1):44-50. doi: 10.4103/JOC.JOC_79_20. Epub 2022 Jan 31.
8
Mutational status may supersede tumor size in predicting the presence of aggressive pathologic features in well differentiated thyroid cancer.在预测高分化甲状腺癌侵袭性病理特征的存在方面,突变状态可能会取代肿瘤大小。
J Otolaryngol Head Neck Surg. 2022 Mar 4;51(1):9. doi: 10.1186/s40463-022-00559-9.
9
Poorly Differentiated Thyroid Carcinoma: Single Centre Experience and Review of the Literature.低分化甲状腺癌:单中心经验及文献综述
J Clin Med. 2021 Nov 12;10(22):5258. doi: 10.3390/jcm10225258.
10
Focal Thyroid Incidentalomas on F-FDG PET/CT: A Systematic Review and Meta-Analysis on Prevalence, Risk of Malignancy and Inconclusive Fine Needle Aspiration.F-FDG PET/CT 下甲状腺偶发结节:基于患病率、恶性风险及细针抽吸活检不确定结果的系统评价和荟萃分析
Front Endocrinol (Lausanne). 2021 Oct 20;12:723394. doi: 10.3389/fendo.2021.723394. eCollection 2021.

本文引用的文献

1
The prediction of malignant risk in the category "atypia of undetermined significance/follicular lesion of undetermined significance" of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results.应用亚分类和 BRAF 突变结果对甲状腺细胞病理学报告的 Bethesda 系统中“意义不明确的非典型性/滤泡性病变意义不明确”类别进行恶性风险预测。
Cancer Cytopathol. 2014 May;122(5):368-76. doi: 10.1002/cncy.21396. Epub 2014 Mar 3.
2
Comparison of the diagnostic accuracy of thyroid fine-needle aspiration in follicular-patterned lesions using a 5-tiered and a 6-tiered diagnostic system: a double-blind study of 140 cases with histological confirmation.使用五级和六级诊断系统比较甲状腺细针穿刺对滤泡样病变的诊断准确性:一项对140例经组织学证实病例的双盲研究。
Diagn Cytopathol. 2014 Sep;42(9):744-50. doi: 10.1002/dc.23115. Epub 2014 Feb 19.
3
Rates of thyroid malignancy by FNA diagnostic category.甲状腺恶性肿瘤的细针抽吸诊断分类比例。
J Otolaryngol Head Neck Surg. 2013 Dec 20;42(1):61. doi: 10.1186/1916-0216-42-61.
4
Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS).甲状腺结节分类为贝塞斯达Ⅲ类(不典型/意义未明的滤泡性病变)的恶性率。
Thyroid. 2014 May;24(5):832-9. doi: 10.1089/thy.2013.0317. Epub 2014 Mar 10.
5
'Suspicious for a follicular neoplasm' before and after the Bethesda System for Reporting Thyroid Cytopathology: impact of standardized terminology.
Acta Cytol. 2013;57(5):455-63. doi: 10.1159/000351664. Epub 2013 Sep 7.
6
The Bethesda system for reporting thyroid fine needle aspiration cytology: a study comparing the results of two centers from two different countries.
Ann Pathol. 2012 Dec;32(6):e29-34, 415-20. doi: 10.1016/j.annpat.2012.09.204. Epub 2012 Nov 22.
7
The impact of implementation of the Bethesda System for Reporting Thyroid Cytopathology on the surgical treatment of thyroid nodules.《贝塞斯达甲状腺细胞病理学报告系统》的实施对甲状腺结节手术治疗的影响。
Am Surg. 2012 Jun;78(6):706-10.
8
Thyroid fine needle aspirate: a post-Bethesda update.甲状腺细针抽吸:贝塞斯达更新后。
Adv Anat Pathol. 2012 May;19(3):160-9. doi: 10.1097/PAP.0b013e3182534610.
9
The use of the Bethesda terminology in thyroid fine-needle aspiration results in a lower rate of surgery for nonmalignant nodules: a report from a reference center in Turkey.在甲状腺细针穿刺中使用贝塞斯达术语可降低非恶性结节的手术率:来自土耳其一家参考中心的报告。
Int J Surg Pathol. 2011 Dec;19(6):761-71. doi: 10.1177/1066896911415667. Epub 2011 Jul 26.
10
The impact of implementation of the Bethesda System for Reporting Thyroid Cytopathology on the quality of reporting, "risk" of malignancy, surgical rate, and rate of frozen sections requested for thyroid lesions.甲状腺细胞病理学报告贝塞斯达系统实施对报告质量、“恶性风险”、手术率和甲状腺病变冷冻切片请求率的影响。
Cancer Cytopathol. 2011 Oct 25;119(5):315-21. doi: 10.1002/cncy.20174. Epub 2011 Jul 12.

哥伦比亚甲状腺细胞病理学报告的贝塞斯达系统:与肿瘤学和非肿瘤学机构组织病理学诊断的相关性。

The Bethesda system for reporting thyroid cytopathology in Colombia: Correlation with histopathological diagnoses in oncology and non-oncology institutions.

作者信息

Melo-Uribe Mario Alexander, Sanabria Álvaro, Romero-Rojas Alfredo, Pérez Gabriel, Vargas Elga Johanna, Abaúnza María Claudia, Gutiérrez Víctor

机构信息

Department of Surgical Pathology, Universidad de La Sabana, Colombia.

Department of Surgery, Universidad de Antioquia-Hospital Pablo Tobón Uribe, Colombia.

出版信息

J Cytol. 2015 Jan-Mar;32(1):12-6. doi: 10.4103/0970-9371.155224.

DOI:10.4103/0970-9371.155224
PMID:25948937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4408670/
Abstract

AIM

To determine the correlation between the results of thyroid fine-needle aspirations interpreted using the Bethesda system and final histopathological reports for patients at an oncology hospital (OH) and non-oncology hospitals (NOHs).

MATERIALS AND METHODS

A retrospective, cross-sectional, descriptive study was performed to compare the cytology and histopathology results for patients with thyroid nodules in three Colombian hospitals. The final correlation of diagnoses between the two methods is reported. In Colombia, the health system provides the existence of general care hospitals and hospitals specializing in care of patients with cancer.

RESULTS

A total of 196 reports were reviewed, of which 53% were from OH and 47% were from NOHs. A greater proportion of category V (37.5%) was diagnosed at the OH, whereas NOHs diagnosed a greater proportion of category II (42.3%). The global correlation between diagnoses made using cytology and histopathology was 93.3% for categories V and VI (based on the final malignant diagnosis) and 86.9% for benign category II. Significant differences between institution types were observed when category IV and V and malignant histopathology were compared (56.3% OH vs. 23.5% NOH; P = 0.05 for category IV, 97.4% OH vs. 82.3% NOH; P = 0.03 for category V), while no significant difference between institution types was observed when category II and final benign diagnosis were compared (P = 0.6).

CONCLUSIONS

The Bethesda system for thyroid cytology correlates adequately with final histopathological diagnosis in Colombia. Significant differences were identified in the diagnostic correlation for malignant lesions between the OH and NOHs in categories IV and V caused by selection bias of the population.

摘要

目的

确定在一家肿瘤医院(OH)和非肿瘤医院(NOHs)中,使用贝塞斯达系统解读的甲状腺细针穿刺结果与患者最终组织病理学报告之间的相关性。

材料与方法

进行了一项回顾性、横断面描述性研究,以比较三家哥伦比亚医院甲状腺结节患者的细胞学和组织病理学结果。报告了两种方法之间诊断的最终相关性。在哥伦比亚,卫生系统提供综合医院和专门治疗癌症患者的医院。

结果

共审查了196份报告,其中53%来自OH,47%来自NOHs。OH诊断出更高比例的V类(37.5%),而NOHs诊断出更高比例的II类(42.3%)。对于V类和VI类(基于最终恶性诊断),细胞学和组织病理学诊断之间的总体相关性为93.3%,良性II类为86.9%。比较IV类和V类以及恶性组织病理学时,观察到机构类型之间存在显著差异(IV类:OH为56.3%,NOHs为23.5%;P = 0.05;V类:OH为97.4%,NOHs为82.3%;P = 0.03),而比较II类和最终良性诊断时,未观察到机构类型之间的显著差异(P = 0.6)。

结论

在哥伦比亚,甲状腺细胞学的贝塞斯达系统与最终组织病理学诊断具有充分的相关性。由于人群选择偏倚,OH和NOHs在IV类和V类恶性病变的诊断相关性方面存在显著差异。